Proving the Business Case for the Internet of Things

Smart Meter and Validic integration aids diabetes management

Steve Rogerson
August 8, 2018



Florida-based Smart Meter has integrated its iGlucose cellular diabetes care product with Validic’s data connectivity platform to bring simple, convenient and affordable diabetes management to people with diabetes, healthcare teams and population management programmes.
 
The iGlucose product, which uses cell-enabled technology to transmit real-time blood glucose results automatically, removes complex technology issues by automatically transmitting real-time blood glucose (BG) results that can be viewed and acted on by a healthcare team.
 
With the integration of iGlucose into the Validic platform, health systems and corporate wellness experts can offer an effective diabetes management programme that fits into busy lives. When iGlucose users check their blood glucose, the healthcare team can receive near real-time, actionable data and has the information to treat their patients confidently.
 
"Complicated and costly technology will not be readily adopted by most people and presents a major barrier to usage," said Cliff McIntosh, CEO of Smart Meter. “IGlucose keeps data management simple and eliminates unnecessary steps and equipment to transfer health information. Patient data can be easily shared in real time so individuals and populations can be managed more effectively and efficiently. Our collaboration with Validic enables us to seamlessly provide data to a wider group of healthcare professionals, integrate data into various health records and assist in delivering better care to those that need the most attention."
 
This integration is said to demonstrate North Carolina-based Validic's commitment to deliver personal health data simply and seamlessly into the healthcare system and to continue to build connections to connected medical health devices and wearables. By providing tools that enable the access to and analysis of personal health data, Validic powers scalable, personalised and data-driven wellness and remote care programmes.
 
"We are excited to welcome iGlucose to Validic's device ecosystem," said Validic CEO Drew Schiller. "Both of our organisations are committed to improving the management of chronic conditions through the elevation of personal health data to clinical care teams. By combining real-time device data with programmatic care, we can deliver a healthcare experience personalised to the unique needs of a patient and designed for clinician efficiency. Through this partnership, we continue to broaden access to key clinical insights – generated outside the clinical setting – that are necessary to provide effective and targeted treatments and interventions."
 
The iGlucose product eliminates the day-to-day hassles of cables, synching devices and downloading apps for people with diabetes. Healthcare teams can engage patients by viewing real-time results and seeing when their patients' BG results are out of range. It enables and supports the new CMS reimbursable remote patient monitoring programme (CPT 99091) that requires patient-generated, digitally stored data.
 
Validic guides healthcare organisations through the technical complexities associated with accessing and operationalising patient-generated health data. It helps improve operational efficiency and patient outcomes by delivering personal health data from more than 400 home health devices seamlessly into existing clinical workflows.
 
With a data connectivity platform to access and integrate key data and a remote monitoring platform to elevate, analyse and visualise patient-generated data, Validic says its products help healthcare and wellness organisations improve population health and prevention programmes.